Generation Income Properties

Clipper Realty

Wheeler REIT

Curbline Properties Corp.

Presidio Property Trust

Office Properties Income Trust

New York City REIT

Sotherly Hotels

Two Harbors

Lument Finance Trust

United States

LOS ANGELES, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming October 7, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired CTO Realty Growth, Inc. (“CTO” or the “Company”) (NYSE: CTO) securities between February 18, 2021 and June 24, 2025, inclusive (the “Class Period”).

Deadline Alert: CTO Realty Growth, Inc. (CTO) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

NEW YORK , Oct. 3, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against CTO Realty Growth, Inc. ("CTO" or the "Company") (NYSE: CTO) and certain officers.  The class action, filed in the United States District Court for the Middle District of Florida, and docketed under 25-cv-01516, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired CTO securities between February 18, 2021 and June 24, 2025, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.

Pomerantz Law Firm Announces the Filing of a Class Action Against CTO Realty Growth, Inc. and Certain Officers - CTO

– CHS-114, an anti-CCR8 cytolytic antibody, will also be featured in SITC's upcoming webinar series “Targets for Cancer IO: A Deep Dive” on October 22, 2025 – – CHS-114, an anti-CCR8 cytolytic antibody, will also be featured in SITC's upcoming webinar series “Targets for Cancer IO: A Deep Dive” on October 22, 2025 –

Coherus Oncology Announces Poster Presentation at the 40th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)

TOLEDO, Ohio , Oct. 3, 2025 /PRNewswire/ -- Welltower® Inc. (NYSE: WELL) today announced it will release third quarter 2025 financial results after the close of trading on the New York Stock Exchange on Monday, October 27, 2025. The Company will host a conference call and webcast on Tuesday, October 28, 2025, at 9:00 a.m.

Welltower Announces Date of Third Quarter 2025 Earnings Release, Conference Call and Webcast

Are you ready to enjoy a high-dividend lifestyle? Today is a great day to bolster your passive income potential with four stocks featuring forward annual dividend yields that exceed 12% as of Oct.

Discover the Elite Stocks Delivering 12%+ Yields for Ultimate Passive Income Domination

WATERTOWN, Mass., Oct. 03, 2025 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to stimulate the body's immune system for the treatment of cancer and other immune-mediated conditions, today announced that three posters will be presented at the upcoming Society for Immunotherapy of Cancer's (SITC) 40th Annual Meeting, taking place November 5-9, 2025, in National Harbor, Maryland. Details for the poster presentations are as follows:

Werewolf Therapeutics to Present Posters at the Society for Immunotherapy of Cancer's (SITC) 40th Annual Meeting

"Dividends are like rewards for patience and loyalty, a tangible expression of a company's gratitude to its shareholders." -- Peter Lynch

2 Rock-Solid Dividend Stocks with Room to Grow

MIAMI--(BUSINESS WIRE)--Millrose Properties, Inc. (NYSE: MRP, “Millrose”), the Homesite Option Purchase Platform for residential homebuilders, today announced that it will release its financial results for the third quarter ended September 30, 2025, before the market opens on Thursday, October 23, 2025. The Company will host a conference call the same day at 10:00 AM ET. The conference call and webcast, as well as relevant earnings materials, will be available through the investor relations sec.

Millrose Properties Announces Date of Third Quarter 2025 Earnings Release and Conference Call

Data center stocks have done well in the past few years as demand for computing powers jumped. This growth may continue in the coming years as analysts predict robust spending in the industry.

Top 3 data center stocks to buy as BlackRock nears deal to buy Aligned

Bragar Eagel & Squire, P.C.  Litigation Partner  Brandon Walker  Encourages Investors Who Suffered Losses In CTO To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in  CTO between February 18, 2021 and June 24, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648.

CTO DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors of the October 7th Deadline in the CTO Class Action Lawsuit and Urges Investors to Contact the Firm

Retirees and older individuals are among the biggest demographics who tune into Jim Cramer's Mad Money show.

2 Dividend Stocks That Jim Cramer Wants Every Retiree to Own

Six independent firms cite brainpowa's benchmark-beating scalability, Microsoft & Google partnerships, repeatable M&A success and accelerated revenue outlook Six independent firms cite brainpowa's benchmark-beating scalability, Microsoft & Google partnerships, repeatable M&A success and accelerated revenue outlook

Wall Street Analysts Boost Rezolve Ai Targets, Validate Path to $500M ARR

PHILADELPHIA and VANCOUVER, British Columbia, Oct. 03, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, is pleased to announce that the Company will be presenting preclinical Bria-OTS+ data at a poster presentation at the Society for Immunotherapy of Cancer (SITC) 40th Anniversary Annual Meeting, held November 7-9, 2025, in National Harbor, MD. The details are listed below.

BriaCell to Present Bria-OTS+™ Preclinical Data at SITC 2025 Annual Meeting

MALVERN, Pa., Oct. 02, 2025 (GLOBE NEWSWIRE) -- CubeSmart (NYSE: CUBE) today announced that the Company will release financial results for the three-month period ended September 30, 2025 after the market close on Thursday, October 30, 2025. An accompanying conference call will be held at 11:00 a.m. ET on Friday, October 31, 2025.

CubeSmart Announces the Date of Its Third Quarter 2025 Earnings Release and Conference Call

NEW YORK--(BUSINESS WIRE)-- #creditratingagency--KBRA assigns preliminary ratings to eight classes of mortgage-backed certificates from Angel Oak Mortgage Trust 2025-10 (AOMT 2025-10), a $281.2 million non-prime RMBS transaction. The underlying collateral, comprised of 608 residential mortgages, is characterized by a significant concentration of loans underwritten using alternative income documentation. All the loans are either classified as exempt (54.1%) from the Ability-to-Repay/Qualified Mortgage rule due to bei.

KBRA Assigns Preliminary Ratings to Angel Oak Mortgage Trust 2025-10 (AOMT 2025-10)

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In CTO To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in CTO between February 18, 2021 and June 24, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330  (Ext. 1310). [You may also click here for additional information] NEW YORK , Oct. 3, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against CTO Realty Growth, Inc. ("CTO" or the "Company") (NYSE: CTO) and reminds investors of the October 7, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of CTO Realty

AGNC Investment (AGNC 0.76%) offers one of the highest dividend yields at nearly 15%. That's over 10 times higher than the S&P 500's current near-historic low yield of less than 1.2% and more than twice the yield of Healthpeak Properties (DOC -0.08%), around 6.5%.

Is AGNC Investment a Better Dividend Stock Than Healthpeak Properties?

WAKEFIELD, Mass.--(BUSINESS WIRE)--Franklin Street Properties Corp. (“FSP”, “our” or “we”) (NYSE American: FSP) announced today that its Board of Directors declared a quarterly dividend of $0.01 per share of common stock for the period July 1, 2025 through September 30, 2025, payable on November 6, 2025 to stockholders of record as of October 17, 2025. This press release, along with other news about FSP, is available on the Internet at www.fspreit.com. We routinely post information that may be.

Franklin Street Properties Corp. Declares Quarterly Dividend

NEEDHAM, Mass., Oct. 03, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today announced the Company will present insights from its enLIGHTEN™ Discovery Platform, and additional data from the CAN-2409 (aglatimagene besadenovec) program in non-small cell lung cancer (NSCLC), through two accepted poster presentations at the Society for Immunotherapy of Cancer's (SITC) 40th Anniversary Annual Meeting, taking place November 5-9, 2025 in National Harbor, Maryland.

Candel Therapeutics to Present at the SITC 2025 Annual Meeting

NEW YORK--(BUSINESS WIRE)--Annaly Capital Management, Inc. Announces Dates of Third Quarter 2025 Financial Results and Conference Call.

Annaly Capital Management, Inc. Announces Dates of Third Quarter 2025 Financial Results and Conference Call

ARLINGTON, Va.--(BUSINESS WIRE)--AVALONBAY COMMUNITIES, INC. (NYSE: AVB) (the “Company”) will release its third quarter 2025 earnings on October 29, 2025 after the market close. The Company will hold a conference call on October 30, 2025 at 1:00 PM Eastern Time (ET) to discuss its third quarter 2025 results. Live Conference Call Details Domestic: (877) 407-9716 International: (201) 493-6779 Webcast: https://investors.avalonbay.com Details for the Replay of the Conference Call Domestic: (844) 51.

AvalonBay Communities, Inc. Announces Third Quarter 2025 Earnings Release Date

SAN DIEGO , Oct. 2, 2025 /PRNewswire/ -- Realty Income Corporation (Realty Income, NYSE: O), The Monthly Dividend Company®, today announced it will release its third quarter 2025 operating results after the New York Stock Exchange closes on November 3, 2025. Following publication of this earnings release, the company will host its quarterly investor call at 2:00 p.m.

Realty Income Announces Third Quarter 2025 Earnings Release Date

BOSTON and LONDON, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing novel payload antibody drug conjugates (ADCs), today announced its abstract has been accepted for oral presentation at the 40 th Annual SITC Meeting being held November 5-9, 2025 in National Harbor, MD.

Akari Therapeutics Announces Abstract Accepted for Oral Presentation at the 40th Annual Society for Immunotherapy of Cancer (SITC) Meeting

WALTHAM, Mass., Oct. 03, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced multiple upcoming poster presentations at the Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting, taking place from November 6-9, 2025 at the Gaylord National Convention Center in National Harbor, Maryland.

Xilio Therapeutics Announces Upcoming Presentations at the Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting

Vancouver, British Columbia--(Newsfile Corp. - October 2, 2025) - THEMAC Resources Group Limited (TSXV: MAC) ("THEMAC" or the "Company") reminds its shareholders to vote ahead of the proxy voting deadline for the upcoming special meeting of shareholders (the "Meeting"). At the Meeting, shareholders will be asked to pass a special resolution (the "Arrangement Resolution") approving an arrangement involving the Company and Tulla Resources Group Pty.

Themac Resources Reminds Shareholders to Vote in Advance of Upcoming Special Meeting

NEW YORK, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against CTO Realty Growth, Inc. (“CTO” or “the Company”) (NYSE: CTO) and certain of its officers.

CTO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that CTO Realty Growth, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

PHILADELPHIA, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Brandywine Realty Trust (the “Company”) (NYSE: BDN) announced today that its operating partnership, Brandywine Operating Partnership, L.P. (the “Operating Partnership”), has closed its previously announced underwritten public offering of $300 million of its 6.125% guaranteed notes due 2031 (the “Notes”).

Brandywine Realty Trust Announces Closing of $300 Million Offering of 6.125% Guaranteed Notes Due 2031

SOUTH SAN FRANCISCO, Calif., Oct. 03, 2025 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (“ALX Oncology” or “the Company”) (Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients' lives, today announced updated data from its Phase 2 ASPEN-06 (NCT05002127) trial will be presented during a poster session at the Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting taking place November 5–9, 2025, in National Harbor, Maryland. The Phase 2 trial evaluated evorpacept, the Company's lead therapeutic candidate, in combination with HERCEPTIN® (trastuzumab), CYRAMZA® (ramucirumab) and paclitaxel, for patients with previously treated HER2-positive advanced gastric cancer (GC) and gastroesophageal junction (GEJ) cancer.

ALX Oncology to Present Updated Data from Phase 2 ASPEN-06 Trial, Highlighting CD47 Expression as a Predictive Biomarker in HER2+ Gastric Cancer, at 40th Society for Immunotherapy of Cancer (SITC) Annual Meeting

W. P. Carey

Public Storage

Prologis

Alexandria

Realty Income

STAG Industrial

Essex Property

Crown Castle

Mid-America

Medical Properties Trust

Outstanding dividend history and a safe payout ratio

Best Dividend REITs

Top Scorers

The 10 most popular REITs by page views on alreits

Dividend Streak 20y

REITs that have been growing dividends for more than 10 years

Dividend Growth Streak 10y

Equity REITs that have been reporting bad results over the last few years and therefore are considered riskier for a beginner investor

Equity REITs to Avoid

REITs that have been reporting good results and are easier to understand for a beginner investor

REITs For Beginners

All Equity REITs

Top Equity REITs with 5-Year Earnings per Share Growth, Ranked by Discount to 52-Week High

Discount to 52-week High

REITs with the lowest Debt/Assets ratio and a positive 5-year CAGR Earnings per Share growth

Low Leverage

REITs that offer a higher starting yield without compromising growth and dividend safety - the sweet spot for income-focused investors

Sweet Spot

European Residential REIT

Dream Office

Allied Properties

BTB REIT

Inovalis REIT

American Hotel Income Properties REIT LP

Killam Apartment

Morguard REIT

Plaza Retail

Chartwell Retirement Residences

Canada

Choice Properties Real Est Invstmnt Trst (TSE:CHP.UN – Get Free Report) was downgraded by equities research analysts at National Bankshares from an “outperform” rating to a “sector perform” rating in a research report issued to clients and investors on Thursd…

Choice Properties Real Est Invstmnt Trst (TSE:CHP.UN) Stock Rating Lowered by National Bankshares

Allied Properties Real Estate Investment Trust (TSE:AP.UN – Get Free Report) has been given a consensus recommendation of “Hold” by the eight ratings firms that are currently covering the stock, Marketbeat.com reports. One equities research analyst has rated …

Allied Properties Real Estate Investment Trust (TSE:AP.UN) Receives Consensus Rating of “Hold” from Brokerages

First Capital Real Estate Investment Trust (TSE:FCR.UN – Get Free Report)’s share price crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of C$17.84 and traded as high as C$19.65. First Capital Real Est…

First Capital Real Estate Investment Trust (TSE:FCR.UN) Stock Price Passes Above Two Hundred Day Moving Average – Time to Sell?

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual investors, professional money managers, active traders, and corpor…

European Residential REIT price target lowered by C$1.75 at CIBC

Minto Apartment Real Estate Invt Trust (TSE:MI.UN – Get Free Report) has been assigned a consensus recommendation of “Hold” from the seven research firms that are presently covering the company, MarketBeat Ratings reports. Four analysts have rated the stock w…

Minto Apartment Real Estate Invt Trust (TSE:MI.UN) Receives C$15.72 Consensus PT from Brokerages

Shares of InterRent Real Estate Investment Trust (TSE:IIP.UN – Get Free Report) have received an average rating of “Hold” from the eight ratings firms that are currently covering the firm, MarketBeat Ratings reports. Two research analysts have rated the stock…

InterRent Real Estate Investment Trust (TSE:IIP.UN) Receives C$13.27 Average PT from Analysts

TORONTO, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Canadian Apartment Properties Real Estate Investment Trust (“CAPREIT”) (TSX:CAR.UN) announced today it will issue its financial results for the three and nine months ended September 30, 2025 after markets close on:

CAPREIT Announces Timing of Third Quarter 2025 Results & Conference Call

Dream Industrial Real Estate Investment Trust (OTCMKTS:DREUF – Get Free Report)’s stock price traded up 0.7% on Monday . The company traded as high as $8.94 and last traded at $8.91. 117,747 shares traded hands during mid-day trading, an increase of 178% from…

Dream Industrial Real Estate Investment Trust (OTCMKTS:DREUF) Trading 0.7% Higher – Here’s Why

NorthWest Healthcare

Dream Industrial

RioCan

InterRent

SmartCentres

Choice Properties

CAPREIT

Granite REIT

The 10 most popular Canadian REITs by page views on alreits

REITs that have been growing dividends for more than 5 years

Dividend Growth Streak 5y

All REITs

Ascott Residence Trust

Lendlease Global Commercial REIT

Suntec Real Estate Investment Trust

CapitaLand China Trust

CDL Hospitality Trusts

Prime US REIT

CapitaLand Integrated Commercial Trust

Keppel Pacific Oak US REIT

AIMS APAC REIT

IREIT Global

Singapore

Keppel REIT

Frasers Centrepoint Trust

Ascendas Real Estate Investment Trust

Mapletree Industrial Trust

Parkway Life Real Estate Investment Trust

Keppel DC REIT

Mapletree Logistics Trust

The 5 most popular REITs by page views on alreits

Town Centre Securities PLC

Land Securities Group plc

Great Portland Estates Plc

British Land Company Plc

Derwent London Plc

Custodian REIT Plc

Empiric Student Property plc

Assura Plc

The PRS REIT plc

LondonMetric Property Plc

United Kingdom

Big Yellow Group Plc

SEGRO Plc

Tritax Big Box REIT plc

Safestore Holdings plc

Unite Group Plc

The 5 most popular UK REITs by page views on alreits

UK REITs with the Largest Discount from Their 52-Week High

Fonciere Inea S.A.

Argan SA

Covivio

Acanthe Développement

Carmila S.A.

Immobiliere Dassault SA

Klépierre

Altarea SCA

Icade

Mercialys

France

Icade (OTCMKTS:CDMGF – Get Free Report) is expected to be posting its results before the market opens on Tuesday, October 7th. Analysts expect Icade to post earnings of $1.67 per share for the quarter. Icade Price Performance CDMGF stock opened at $25.14 on T…

SMARTER REIT INVESTING STARTS HERE

United States

Sectors

Gainers Today

Losers Today

Popular REITs

News

Explore

Canada

@-webkit-keyframes mui-auto-fill{from{display:block;}}@keyframes mui-auto-fill{from{display:block;}}@-webkit-keyframes mui-auto-fill-cancel{from{display:block;}}@keyframes mui-auto-fill-cancel{from{display:block;}}Sectors

Sectors

Gainers Today

Losers Today

Popular REITs

News

Explore

Singapore

@-webkit-keyframes mui-auto-fill{from{display:block;}}@keyframes mui-auto-fill{from{display:block;}}@-webkit-keyframes mui-auto-fill-cancel{from{display:block;}}@keyframes mui-auto-fill-cancel{from{display:block;}}Sectors

Sectors

Gainers Today

Losers Today

Popular REITs

News

Explore

United Kingdom

@-webkit-keyframes mui-auto-fill{from{display:block;}}@keyframes mui-auto-fill{from{display:block;}}@-webkit-keyframes mui-auto-fill-cancel{from{display:block;}}@keyframes mui-auto-fill-cancel{from{display:block;}}Sectors

Sectors

Gainers Today

Losers Today

Popular REITs

News

Explore

France

@-webkit-keyframes mui-auto-fill{from{display:block;}}@keyframes mui-auto-fill{from{display:block;}}@-webkit-keyframes mui-auto-fill-cancel{from{display:block;}}@keyframes mui-auto-fill-cancel{from{display:block;}}Sectors

Sectors

Gainers Today

Losers Today

Popular REITs

News

Explore

Dividend income is one of the primary reasons to invest in REITs, in large part because their yields represent an attractive premium to yields offered by other investments.

SMARTER REIT INVESTING
STARTS HERE

Sectors

Sectors

Sectors

Sectors